Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Cancer Biology & Therapy|February 18, 2009
Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activityCarmen Plasencia, Fedora Grande, Takashi Oshima, et al.
Surgery Today|January 24, 2007
Spleen-preserving distal pancreatectomy combined with distal gastrectomy for distal pancreatic lesion and gastric cancer: Report of a caseYuichi Otsuka, Chikara Kunisaki, Hidetaka Ono, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 27, 2025
[Surgical Resection of an Ascending Colon Tumor Suspected to Represent Intestinal Behçet's Disease-A Case Report]Kentaro Funaoka, Roppei Yamada, Rei Hatayama, et al.
Hepato-Gastroenterology|July 17, 2007
Modified POSSUM to predict postoperative morbidity following gastrectomyYuichi Otsuka, Chikara Kunisaki, Hidetaka Ono, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2012
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatmentShili Xu, Alexey N Butkevich, Roppei Yamada, et al.
Molecular Cancer|April 17, 2015
Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancerShiro Koizume, Shin Ito, Yoshiyasu Nakamura, et al.
Hepato-Gastroenterology|July 17, 2007
Lateral lymph node dissection for lower rectal cancerManabu Shiozawa, Makoto Akaike, Roppei Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2006
[Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer]Takashi Ohshima, Roppei Yamada, Shinsuke Hatori, et al.
Anticancer Research|April 20, 2006
A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancerYasushi Rino, Yoshinori Takanashi, Norio Yukawa, et al.
Clinical Medicine Insights. Oncology|June 23, 2010
A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second ReportYasushi Rino, Norio Yukawa, Hitoshi Murakami, et al.
Pageof 5